These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 833854)

  • 1. Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.
    Kern DH; Drogemuller CR; Chow N; Holleman DD; Pilch YH
    J Natl Cancer Inst; 1977 Jan; 58(1):117-21. PubMed ID: 833854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediation of cytotoxic immune responses against human tumor-associated antigens by xenogeneic immune RNA.
    Kern DH; Fritze D; Drogemuller CR; Pilch YH
    J Natl Cancer Inst; 1976 Jul; 57(1):97-103. PubMed ID: 1003510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediation of immune responses to tumor antigens in vitro by immune RNA.
    Kern DH; Drogemuller CR; Pilch YH
    Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
    Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
    J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2.
    Hersey P; Bindon C; Edwards A; Murray E; Phillips G; McCarthy WH
    Int J Cancer; 1981 Dec; 28(6):695-703. PubMed ID: 6977498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
    Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
    O'Neill PA; Mackler BF; Romsdahl MM
    J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human lymphoblastoid cells in culture replicate immune information carried by xenogeneic RNA.
    Viza D; Boucheix C; Kern DH; Pilch YH
    Differentiation; 1978; 11(3):181-4. PubMed ID: 720786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune cytolysis of human renal carcinoma mediated by xenogeneic immune ribonucleic acid.
    Brower PA; Dekernion JB; Ramming KP
    J Urol; 1976 Mar; 115(3):243-5. PubMed ID: 1255883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation in vitro of mouse macrophages by syngeneic, allogeneic, or xenogeneic lymphocyte supernatants.
    Fidler IJ
    J Natl Cancer Inst; 1975 Nov; 55(5):1159-63. PubMed ID: 1206741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cell-mediated immune reactions of melanoma and colorectal carcinoma patients demonstrated by long-term 51chromium assays.
    Steele G; Sjögren HO; Stadenberg I
    Int J Cancer; 1976 Jan; 17(1):27-39. PubMed ID: 1248900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
    Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
    J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated cytotoxicity for cultured autologous melanoma cells.
    Livingston PO; Shiku H; Bean MA; Pinsky CM; Oettgen HF; Old LJ
    Int J Cancer; 1979 Jul; 24(1):34-44. PubMed ID: 478690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of immune RNA in the immunotherapy of malignant brain tumor (author's transl)].
    Nakamura O; Takakura K
    No To Shinkei; 1982 Apr; 34(4):333-9. PubMed ID: 6178420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.
    Mukherji B; Nashed AL; Guha A; Ergin MT
    J Immunol; 1986 Mar; 136(5):1893-8. PubMed ID: 2419419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
    Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
    Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
    Wilhelm SA; Mukherji B
    J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures.
    Knuth A; Danowski B; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3511-5. PubMed ID: 6610177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects.
    Sulit HL; Golub SH; Irie RF; Gupta RK; Grooms GA; Morton DL
    Int J Cancer; 1976 Apr; 17(4):461-8. PubMed ID: 945229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of tumor specific immunity with "immune" RNA: prospects for the treatment of human cancer.
    Fritze D; Kern DH; Pilch YH
    Klin Wochenschr; 1976 Sep; 54(18):851-63. PubMed ID: 787654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.